Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $15.0300 (-1.64%) ($14.6500 - $15.7500) on Sat. May. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.09% (three month average) | RSI | 70 | Latest Price | $15.0300(-1.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 6.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 6.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -3.045% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.045% (StdDev 6.09%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $12.5(20.24%) | 10 Day Moving Average | $11.83(27.05%) | 20 Day Moving Average | $11.48(30.92%) | To recent high | -1.6% | To recent low | 60.2% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |